IPU, Wednesday 18 November 2026: The Irish Pharmacy Union (IPU) is pleased to announce the publication of a new peer-reviewed study based on its’ annual Medicine Shortages Survey, one of the most comprehensive assessments of medicines supply challenges facing community pharmacies in Ireland. The study highlights the ongoing challenges of medicines shortages on patients, pharmacists and the healthcare services in Ireland.
Published in Exploratory Research in Clinical and Social Pharmacy, the study, “A Cross-Sectional Evaluation of Medicine Shortages in Community Pharmacy: Implications for Patients, Pharmacists and Clinical Service Expansion”, was conducted by researchers from Trinity College Dublin, the Irish Pharmacy Union, University College Cork and South East Technological University; Yasmin Aminou, Noelle Horan, Dr Susan O’Dwyer, Eoin Mac Uileagoid and Dr Harriet Bennett-Lenane.
The nationwide survey of community pharmacists found that medicines shortages remain a persistent and complex challenge across Ireland. More than 70% of pharmacists reported that shortages have increased over the past year, while almost 80% anticipate further increases in the coming year. Pharmacists reported spending a median of four hours each week managing shortages. Almost 98% of respondents noted that addressing medicine shortages increases workload for pharmacy staff and almost 95% stated medicine shortages led to increased administrative duties. 97% of respondents agreed that addressing medicine shortages increases work-related stress for pharmacy staff.
The study highlights the impacts on patients including treatment interruptions, increased distress and inconvenience, additional costs associated with alternative medicines, and concerns about health outcomes and confidence in the healthcare system.
Respondents reported manufacturer allocations, manufacturing disruptions, market withdrawals and Ireland’s small market size as likely key contributors to shortages. They also reported opportunities to improve the management of shortages through enhanced communication, earlier notification systems, strengthened stakeholder collaboration and measures to facilitate appropriate medicines substitution.
The research identified some potential challenges for expanding pharmacy services. Nearly half of respondents reported challenges prescribing certain medications as part of Ireland’s recently introduced Common Conditions Service due to product unavailability, and almost 90% reported the need for frequent management of shortages for products covered under the free Hormone Replacement Therapy (HRT) initiative.
Commenting on the publication, Susan O’ Dwyer, Head of Professional Services with the IPU and a co-author of the study, said:
“Community pharmacists are at the frontline of medicines shortages every day, working tirelessly to ensure continuity of care for patients. This study highlights that shortages are no longer an occasional challenge but have become a regular component of routine pharmacy practice. The findings reinforce the need for continued collaboration between regulators, policymakers, manufacturers, wholesalers, healthcare professionals and patient representatives to develop sustainable solutions that protect patient access to medicines.”
Ends
About the Study
A Cross-Sectional Evaluation of Medicine Shortages in Community Pharmacy: Implications for Patients, Pharmacists and Clinical Service Expansion was published in Exploratory Research in Clinical and Social Pharmacy in September 2026. The Irish Pharmacy Union-led study collected responses from 270 community pharmacists across Ireland and used a mixed-methods approach to examine the causes, impacts and management of medicines shortages in community pharmacy practice.




